Anonymous
Dec 11, 2023
Gene therapies:- Ex- Vivo gene therapy, In Vivo gene therapy?
1 view
1 view
1 answer
Sort By
ChatGPT
Dec 11, 2023
Ex-Vivo Gene Therapy:
Ex-vivo gene therapy involves the removal of cells from the patient's body, which are then genetically modified in a laboratory setting. The modified cells are then reintroduced into the patient's body. This approach is commonly used for diseases that affect specific cells or tissues, such as certain types of cancer or genetic disorders. The cells are typically modified using viral vectors or other methods to deliver the therapeutic genes into the cells before being reinfused into the patient.
In-Vivo Gene Therapy:
In-vivo gene therapy involves the direct delivery of therapeutic genes into the patient's body, without the need for cell removal or manipulation. This approach is used when the target cells or tissues can be accessed directly, such as through injection or infusion. In-vivo gene therapy can be achieved through various methods, including the use of viral vectors, non-viral vectors, or gene editing technologies like CRISPR-Cas9. This approach is often used for diseases that affect multiple organs or tissues, such as certain genetic disorders or diseases like muscular dystrophy.
Ex-vivo gene therapy involves the removal of cells from the patient's body, which are then genetically modified in a laboratory setting. The modified cells are then reintroduced into the patient's body. This approach is commonly used for diseases that affect specific cells or tissues, such as certain types of cancer or genetic disorders. The cells are typically modified using viral vectors or other methods to deliver the therapeutic genes into the cells before being reinfused into the patient.
In-Vivo Gene Therapy:
In-vivo gene therapy involves the direct delivery of therapeutic genes into the patient's body, without the need for cell removal or manipulation. This approach is used when the target cells or tissues can be accessed directly, such as through injection or infusion. In-vivo gene therapy can be achieved through various methods, including the use of viral vectors, non-viral vectors, or gene editing technologies like CRISPR-Cas9. This approach is often used for diseases that affect multiple organs or tissues, such as certain genetic disorders or diseases like muscular dystrophy.
0
